Emergence of a vaccine can distract interest of traders from IT sector

Investing.com — If the potential vaccine from Koronavirus will get official approval this year, it threatens with delay of growth of speculative investments in an action of the large technological companies United States of America and will push investors back to more traditional actions connected with cyclic growth, analysts of Goldman Sachs Group, Inc. believe Group Inc (NYSE: GS). Those companies who managed to get profit at the expense of entered for fight against a quarantine and self-isolation virus, such as Apple Inc. (NASDAQ: AAPL), Facebook, Inc (NASDAQ: FB), Amazon.com, Inc..com (NASDAQ: AMZN) and Alphabet (NASDAQ: GOOGL), grew in...